关键词： 骨质疏松症 细胞因子 雌激素 绝经期 绝经期骨质疏松症（postmenopausal osteoporosis,POP)是一种随绝经期年龄增长而出现的全身骨量的减少，并以骨矿物质、骨基质等减少为特征，病理骨折发生的危险性...
基于6个网页-相关网页
方法： 158例老年绝经期骨质疏松症患者随机分为对照组（79例）和观察组（79例）。
METHODS: 158 elderly menopausal patients with osteoporosis were randomly divided into control group (79 cases) and observation group(79 cases).
与三苯氧胺不同的是，芳香抑制剂不会引起绝经期症状，但可增加骨质疏松症危险。
Unlike tamoxifen, aromatase inhibitors do not cause menopausal symptoms, but they may increase risk of osteoporosis.
研究结果表明这种每年一次的疗法能降低所有绝经期后患骨质疏松症各种类型骨折的风险。
Results of the study showed that treatment with zoledronic acid was very effective in reducing the incidence of all types of fractures in women with postmenopausal osteoporosis.
应用推荐